Lactate dehydrogenase kinetics predict chemotherapy response in recurrent metastatic nasopharyngeal carcinoma
L Huang, AYL Sim, Y Wu, Z Liang, K Li… - Therapeutic …, 2020 - journals.sagepub.com
Background: Lactate dehydrogenase (LDH) is a known prognostic biomarker for the
endemic variant of nasopharyngeal carcinoma (NPC). Here, we investigate whether serial …
endemic variant of nasopharyngeal carcinoma (NPC). Here, we investigate whether serial …
Lactate dehydrogenase kinetics predict chemotherapy response in recurrent metastatic nasopharyngeal carcinoma
L Huang, AYL Sim, Y Wu, Z Liang… - Therapeutic …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Lactate dehydrogenase (LDH) is a known prognostic biomarker for the endemic
variant of nasopharyngeal carcinoma (NPC). Here, we investigate whether serial changes in …
variant of nasopharyngeal carcinoma (NPC). Here, we investigate whether serial changes in …
Lactate dehydrogenase kinetics predict chemotherapy response in recurrent metastatic nasopharyngeal carcinoma.
L Huang, AYL Sim, Y Wu, Z Liang, K Li… - … Advances in Medical …, 2020 - europepmc.org
Background Lactate dehydrogenase (LDH) is a known prognostic biomarker for the endemic
variant of nasopharyngeal carcinoma (NPC). Here, we investigate whether serial changes in …
variant of nasopharyngeal carcinoma (NPC). Here, we investigate whether serial changes in …
[HTML][HTML] Lactate dehydrogenase kinetics predict chemotherapy response in recurrent metastatic nasopharyngeal carcinoma
L Huang, AYL Sim, Y Wu, Z Liang, K Li… - … Advances in Medical …, 2020 - ncbi.nlm.nih.gov
Background: Lactate dehydrogenase (LDH) is a known prognostic biomarker for the
endemic variant of nasopharyngeal carcinoma (NPC). Here, we investigate whether serial …
endemic variant of nasopharyngeal carcinoma (NPC). Here, we investigate whether serial …
[PDF][PDF] Lactate dehydrogenase kinetics predict chemotherapy response in recurrent metastatic nasopharyngeal carcinoma
L Huang, AYL Sim, Y Wu, Z Liang, K Li, Y Du… - 2020 - researchgate.net
Background: Lactate dehydrogenase (LDH) is a known prognostic biomarker for the
endemic variant of nasopharyngeal carcinoma (NPC). Here, we investigate whether serial …
endemic variant of nasopharyngeal carcinoma (NPC). Here, we investigate whether serial …
Lactate dehydrogenase kinetics predict chemotherapy response in recurrent metastatic nasopharyngeal carcinoma.
L Huang, AYL Sim, Y Wu, Z Liang, K Li… - Therapeutic …, 2020 - search.ebscohost.com
Background: Lactate dehydrogenase (LDH) is a known prognostic biomarker for the
endemic variant of nasopharyngeal carcinoma (NPC). Here, we investigate whether serial …
endemic variant of nasopharyngeal carcinoma (NPC). Here, we investigate whether serial …
[PDF][PDF] Lactate dehydrogenase kinetics predict chemotherapy response in recurrent metastatic nasopharyngeal carcinoma
L Huang, AYL Sim, Y Wu, Z Liang, K Li, Y Du… - 2020 - pdfs.semanticscholar.org
Background: Lactate dehydrogenase (LDH) is a known prognostic biomarker for the
endemic variant of nasopharyngeal carcinoma (NPC). Here, we investigate whether serial …
endemic variant of nasopharyngeal carcinoma (NPC). Here, we investigate whether serial …
Lactate dehydrogenase kinetics predict chemotherapy response in recurrent metastatic nasopharyngeal carcinoma.
L Huang, AYL Sim, Y Wu, Z Liang, K Li… - … Advances in Medical …, 2020 - europepmc.org
Background Lactate dehydrogenase (LDH) is a known prognostic biomarker for the endemic
variant of nasopharyngeal carcinoma (NPC). Here, we investigate whether serial changes in …
variant of nasopharyngeal carcinoma (NPC). Here, we investigate whether serial changes in …